RU-486 Lower-Dose, Home-Administered Misoprostol Being Evaluated
Executive Summary
The Population Council is planning a trial to demonstrate that a 200 mg dose of the abortifacient Mifeprex is effective and that the misoprostol component of the regimen can be safely used at home.
You may also be interested in...
Pharmacia VP Friedman Is Among PhRMA Favorites For FDA Commissioner
Pharmacia Senior VP Michael Friedman's recent letter to the New England Journal of Medicine regarding the use of Cytotec (misoprostol) in pregnant women should help continue his candidacy to return to FDA as commissioner.
Pharmacia Cytotec Use For Labor Induction Reaffirmed By ACOG
The American College of Obstetricians & Gynecologists is reaffirming its guidelines supporting the use of Pharmacia/Searle's Cytotec (misoprostol) for the induction of labor.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011